Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

ITAT Delhi held that reassessment proceedings under Section 147 cannot be initiated while scrutiny assessment under Section 143(2) is still pending. Such parallel proceedings are without jurisdiction ...

BYD, the Chinese automaker that has rapidly become the world’s largest electric vehicle maker by sales, has introduced a ...